Global Female Fertility & Pregnancy Rapid Test Market Report Size, Trends & Growth Opportunity, By Type (Pregnancy Test Kits, Pregnancy Test Strips, Other), By Application (Retail Stores, Online Stores, Gynaecology and Fertility Clinics, Other), By Region (North America, Europe, Asia Pacific, Latin America, Middle East) And Forecast Till 2027.
Report ID : IR100145 | Industries : Energy & Power | Published On :May 2024 | Page Count : 256
Global Female Fertility & Pregnancy Rapid Test Market Report Size, Trends & Growth Opportunity, By Type (Pregnancy Test Kits, Pregnancy Test Strips, Other), By Application (Retail Stores, Online Stores, Gynaecology and Fertility Clinics, Other), By Region (North America, Europe, Asia Pacific, Latin America, Middle East) And Forecast Till 2027.
Global Female Fertility & Pregnancy Rapid Test Market
Global Female Fertility & Pregnancy Rapid Test Market was valued at US$ 1597.85 Million in 2021, estimated to reach US$ 2137.32 Million in 2027, with a CAGR 4.01% from 2022-2027.
A diagnostic tool used to detect the presence of human chorionic gonadotropin (hCG) in urine is termed as a Female Fertility and Pregnancy Rapid Test. hCG is formed by the placenta and is the earliest detectable marker of pregnancy.
Market Drivers
The global female fertility and pregnancy rapid test market is experiencing substantial growth because of the growing awareness about female fertility and pregnancy among women and couples and increasing incidence of infertility among women.
Also, increasing demand for early detection of female fertility and pregnancy problems fuel the market growth.
Furthermore, there is technological advances in the development of rapid tests for the detection of female fertility and pregnancy problems. Thus, it will propel the market growth.
Market Restraints
Because of the use of advanced technology to forecast precise results immediately, rapid test kits that are available for testing female fertility and pregnancy are costly. As a result, this will hinder the growth of the market.
In addition, Absurdity of choice because of the availability of too many options in the market will hamper the market growth.
Market Segmentation
Female Fertility & Pregnancy Rapid Test Market is segmented into major 4 categories. Based on Type, the market is divided into Pregnancy Test Kits, Pregnancy Test Strips, Other. Based on Application, the market is segmented into Retail Stores, Online Stores, Gynaecology and Fertility Clinics, Other. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East.
Regional Analysis
Based on the region, North America will lead the global market owing to Effective reimbursement policies and price reductions are expected to offer lucrative growth opportunities for players in the market. Additionally, Direct-to-consumer (DTC) medical tests can be a reasonable option to help low-income countries.
Asia Pacific is anticipated to witness substantial growth because of the rise in demand for rapid diagnostic tests related to women's health coupled with increasing government initiatives.
Market Key Players
Some of the key players operating in Global Female Fertility & Pregnancy Rapid Test Market are BioMerieux, Alere, Church & Dwight, Quidel, Clinical Guard, Fairhaven Health, PRIMA Lab, Princeton BioMeditech, Wondfo, Zita West.
Industry development
In June 2021, BioMerieux announced the distribution of specific diagnostics’ REVEAL Rapid AST system in Europe which strengthen the rapid testing kits segment of the market in the European region.
In Aug 2017 Church & Dwight Co., Inc., the makers of First Response™ pregnancy and ovulation tests, announced that they have partnered with four women to create a digital content series sharing the real-life stories of their trying-to-conceive journeys.
Global Female Fertility & Pregnancy Rapid Test Market TOC:
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Feedstock Types
3 Executive Summary
4 Global Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Female Fertility & Pregnancy Rapid Test Market, By Type
5.1 Y-o-Y Growth Comparison, By Type
5.2 Global Female Fertility & Pregnancy Rapid Test Market Share Analysis, By Type
5.3 Global Female Fertility & Pregnancy Rapid Test Market Size and Forecast, By Type
5.3.1 Pregnancy Test Kits
5.3.2 Pregnancy Test Strips
5.3.3 Other
6 Global Female Fertility & Pregnancy Rapid Test Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Female Fertility & Pregnancy Rapid Test Market Share Analysis, By Application
6.3 Global Female Fertility & Pregnancy Rapid Test Market Size and Forecast, By Application
6.3.1 Retail Stores
6.3.2 Online Stores
6.3.3 Gynaecology and Fertility Clinics
6.3.4 Others
7 Global Female Fertility & Pregnancy Rapid Test Market, By Region
7.1 Global Female Fertility & Pregnancy Rapid Test Market Share Analysis, By Region
7.2 Global Female Fertility & Pregnancy Rapid Test Market Share Analysis, By Region
7.3 Global Female Fertility & Pregnancy Rapid Test Market Size and Forecast, By Region
8 North America Global Female Fertility & Pregnancy Rapid Test Market Analysis and Forecast (2022 – 2027)
8.1 Introduction
8.2 North America Global Female Fertility & Pregnancy Rapid Test Market Share Analysis, By Type
8.3 North America Global Female Fertility & Pregnancy Rapid Test Market Size and Forecast, By Application
8.4 North America Global Female Fertility & Pregnancy Rapid Test Market Size and Forecast, By Country
8.4.1 U.S.
8.4.2 Canada
8.4.3 Mexico
9 Europe Global Female Fertility & Pregnancy Rapid Test Market Analysis and Forecast (2022 – 2027)
9.1 Introduction
9.2 Europe Global Female Fertility & Pregnancy Rapid Test Market Share Analysis, By Type
9.3 Europe Global Female Fertility & Pregnancy Rapid Test Market Size and Forecast, By Application
9.4 Europe Global Female Fertility & Pregnancy Rapid Test Market Size and Forecast, By Country
9.4.1 Germany
9.4.2 France
9.4.3 UK
9.4.4. Rest of Europe
10 Asia Pacific Global Female Fertility & Pregnancy Rapid Test Market Analysis and Forecast (2022 – 2027)
10.1 Introduction
10.2 Asia Pacific Global Female Fertility & Pregnancy Rapid Test Market Share Analysis, By Type
10.3 Asia Pacific Global Female Fertility & Pregnancy Rapid Test Market Size and Forecast, By Application
10.4 Asia Pacific Global Female Fertility & Pregnancy Rapid Test Market Size and Forecast, By Country
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4. Rest of Asia Pacific
11 Latin America Global Female Fertility & Pregnancy Rapid Test Market Analysis and Forecast (2022 – 2027)
11.1 Introduction
11.2 Latin America Global Female Fertility & Pregnancy Rapid Test Market Share Analysis, By Type
11.3 Latin America Global Female Fertility & Pregnancy Rapid Test Market Size and Forecast, By Application
11.4 Latin America Global Female Fertility & Pregnancy Rapid Test Market Size and Forecast, By Country
11.4.1. Brazil
11.4.2. Rest of Latin America
12 Middle East Global Female Fertility & Pregnancy Rapid Test Market Analysis and Forecast (2022 – 2027)
12.1 Introduction
12.2 Middle East Global Female Fertility & Pregnancy Rapid Test Market Share Analysis, By Type
12.3 Middle East Global Female Fertility & Pregnancy Rapid Test Market Size and Forecast, By Application
12.4 Middle East Global Female Fertility & Pregnancy Rapid Test Market Size and Forecast, By Country
12.4.1. Saudi Arabia
12.4.2. UAE
12.4.3. Egypt
12.4.4. Kuwait
12.4.5. South Africa
13 Competitive Analysis
13.1 Competition Dashboard
13.2 Market share Analysis of Top Vendors
13.3 Key Development Strategies
14 Company Profiles
14.1 BioMerieux
14.1.1 Overview
14.1.2 Offerings
14.1.3 Key Financials
14.1.4 Business Segment & Geographic Overview
14.1.5 Key Market Developments
14.1.6 Key Strategies
14.2 Alere
14.2.1 Overview
14.2.2 Offerings
14.2.3 Key Financials
14.2.4 Business Segment & Geographic Overview
14.2.5 Key Market Developments
14.2.6 Key Strategies
14.3 Church & Dwight
14.3.1 Overview
14.3.2 Offerings
14.3.3 Key Financials
14.3.4 Business Segment & Geographic Overview
14.3.5 Key Market Developments
14.3.6 Key Strategies
14.4 Quidel
14.4.1 Overview
14.4.2 Offerings
14.4.3 Key Financials
14.4.4 Business Segment & Geographic Overview
14.4.5 Key Market Developments
14.4.6 Key Strategies
14.5 Clinical Guard
14.5.1 Overview
14.5.2 Offerings
14.5.3 Key Financials
14.5.4 Business Segment & Geographic Overview
14.5.5 Key Market Developments
14.5.6 Key Strategies
14.6 Fairhaven Health
14.6.1 Overview
14.6.2 Offerings
14.6.3 Key Financials
14.6.4 Business Segment & Geographic Overview
14.6.5 Key Market Developments
14.6.6 Key Strategies
14.7 PRIMA Lab
14.7.1 Overview
14.7.2 Offerings
14.7.3 Key Financials
14.7.4 Business Segment & Geographic Overview
14.7.5 Key Market Developments
14.7.6 Key Strategies
14.8 Princeton BioMeditech
14.8.1 Overview
14.8.2 Offerings
14.8.3 Key Financials
14.8.4 Business Segment & Geographic Overview
14.8.5 Key Market Developments
14.8.6 Key Strategies
14.9 Wondfo
14.9.1 Overview
14.9.2 Offerings
14.9.3 Key Financials
14.9.4 Business Segment & Geographic Overview
14.9.5 Key Market Developments
14.9.6 Key Strategies
14.10 Zita West
14.10.1 Overview
14.10.2 Offerings
14.10.3 Key Financials
14.10.4 Business Segment & Geographic Overview
14.10.5 Key Market Developments
14.10.6 Key Strategies